Immunovia's CLARITI study was presented in a distinguished plenary session at Digestive Disease Week (DDW) 2025 and was further recognized in the conference's closing session, Best of DDW. The selection highlights the study's exceptional scientific and clinical significance and places it among the most impactful research presented at the world's largest conference in gastroenterology. "This recognition reinforces the strength of our clinical valid

MemorialCare Heart & Vascular Institute (MHVI) at Saddleback Medical Center is proud to announce today the addition of two esteemed cardiothoracic surgeons to its program: Dr. Asad Shah and Dr. Timothy Lee. Their expertise brings expanded cardiothoracic surgical options – including more minimally invasive and robotic-assisted procedures – closer to home for patients in the South Orange County community. "We are thrilled to welcome Dr. Asad Shah and Dr. Timothy L

GE HealthCare today announced an intended expansion of its radiation oncology portfolio as well as the introduction of the new AI-enabled MR Contour DL™ at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2025 Congress in Vienna, Austria. The company will also showcase its updated Intelligent Radiation Therapy (iRT), a software solution that standardizes complex workflows, helping to enable a shorter timeline from diagnosis to treatment and more precise radiation

EnChannel Medical, a breakthrough innovator in cardiac electrophysiology, today announced the successful completion of an oversubscribed Series B financing, raising $82.2M (600M RMB). The round was co-led by Dragonball Capital and existing investor Lilly Asia Ventures (LAV), with continued strong support from Lapam Capital. This financing marks one of the largest private investments in China's medical device sector since 2023. EnChannel's previously completed its Series A ro

Andor Health, the AI company reimagining virtual care with the #1 AI software infrastructure for healthcare, expands AI-first ThinkAndor® capabilities at Sentara Health. Sentara is among the top 20 largest not-for-profit integrated health systems in the country, with 34,000 employees, 12 hospitals in Virginia and Northeastern North Carolina, and the Sentara Health Plans division which serves more than 1 million members in Virginia and Florida. Considering the early success of im

MolecuLight Inc., a global pioneer in point-of-care fluorescence imaging for rapid detection of infection causing bacteria in wounds, today announced the immediate availability of its new Thermal Imaging Module for the MolecuLightDX™ fluorescence imaging platform. This innovative clip-on module allows clinicians using the DX device to capture informative thermal images simultaneously with the platform's established fluorescence images (for bacterial load assessment) and standard ima

BayCare, the leading health care system in West Central Florida, broke ground today on BayCare Hospital Manatee, its 17th hospital, and BayCare HealthHub® (Manatee). This milestone marks a significant step in expanding access to health care for the growing Manatee County community. The hospital will be the county's first not-for-profit hospital and the only hospital north of the Manatee River. "Today is an exciting day as this groundbreaking represents BayCare's ong

Guardant Health, Inc. a leading precision oncology company, presented data today from a study showing that its methylation-based Shield™ multi-cancer detection (MCD) test demonstrated high specificity and clinically meaningful sensitivity across ten tumor types,* while also providing information to guide clinical diagnostic evaluation. The study was presented at the 2025 American Association for Cancer Research (AACR) annual meeting. Results of the study served as the basis for the

MolecuLight Corp., a global pioneer in point-of-care fluorescence imaging for rapid detection of infection causing bacteria in wounds, and DocNow, an innovative post-acute Electronic Health Record (EHR) platform, today announced their integration for the MolecuLightDX™ device. This powerful collaboration will streamline clinical workflows by enabling seamless data and image transfer from the MolecuLightDX device directly into DocNow. Importantly, this integration extends compr

Gestalt, a leading innovator in AI-powered digital pathology solutions, announced the completion of a $7.5 million Series A financing. The round was led by Cowles Ventures, TVF Funds, Inland Imaging Investments, KickStart Funds, and prominent angel investors from the Pacific Northwest. Gestalt's PathFlow® platform is used by leading healthcare, academic medical centers, and research organizations. Customers implement PathFlow as their preferred solution because it integrates